4.7 Article

Stearylamine Liposomal Delivery of Monensin in Combination with Free Artemisinin Eliminates Blood Stages of Plasmodium falciparum in Culture and P-berghei Infection in Murine Malaria

Journal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 60, Issue 3, Pages 1304-1318

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01796-15

Keywords

-

Funding

  1. Delhi University Department of Science and Technology
  2. Delhi University
  3. ICMR project funding, Government of India
  4. University Grant Commission
  5. Council for Scientific and Industrial Research

Ask authors/readers for more resources

The global emergence of drug resistance in malaria is impeding the therapeutic efficacy of existing antimalarial drugs. Therefore, there is a critical need to develop an efficient drug delivery system to circumvent drug resistance. The anticoccidial drug monensin, a carboxylic ionophore, has been shown to have antimalarial properties. Here, we developed a liposome-based drug delivery of monensin and evaluated its antimalarial activity in lipid formulations of soya phosphatidylcholine (SPC) cholesterol (Chol) containing either stearylamine (SA) or phosphatidic acid (PA) and different densities of distearoyl phosphatidylethanolamine-methoxy-polyethylene glycol 2000 (DSPE-mPEG-2000). These formulations were found to be more effective than a comparable dose of free monensin in Plasmodium falciparum (3D7) cultures and established mice models of Plasmodium berghei strains NK65 and ANKA. Parasite killing was determined by a radiolabeled [H-3] hypoxanthine incorporation assay (in vitro) and microscopic counting of Giemsa-stained infected erythrocytes (in vivo). The enhancement of antimalarial activity was dependent on the liposomal lipid composition and preferential uptake by infected red blood cells (RBCs). The antiplasmodial activity of monensin in SA liposome (50% inhibitory concentration [IC50], 0.74 nM) and SPC: Chol-liposome with 5 mol% DSPE-mPEG 2000 (IC50, 0.39 nM) was superior to that of free monensin (IC50, 3.17 nM), without causing hemolysis of erythrocytes. Liposomes exhibited a spherical shape, with sizes ranging from 90 to 120 nm, as measured by dynamic light scattering and high-resolution electron microscopy. Monensin in long-circulating liposomes of stearylamine with 5 mol% DSPE-mPEG 2000 in combination with free artemisinin resulted in enhanced killing of parasites, prevented parasite recrudescence, and improved survival. This is the first report to demonstrate that monensin in PEGylated stearylamine (SA) liposome has therapeutic potential against malaria infections.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Pharmacology & Pharmacy

Polo-like Kinase 1 as an emerging drug target: structure, function and therapeutic implications

Ilma Shakeel, Neha Basheer, Gulam Mustafa Hasan, Mohammad Afzal, Md. Imtaiyaz Hassan

Summary: PLK1, a conserved mitotic serine-threonine protein kinase, plays important roles in cell division and genome stability. Its expression is controlled by cell cycle stages and blocking PLK1 expression can inhibit tumor cell proliferation and induce apoptosis, making it an attractive target for drug development.

JOURNAL OF DRUG TARGETING (2021)

Review Pharmacology & Pharmacy

Emerging Therapeutic Approaches to COVID-19

Indrakant K. Singh, Pratibha Kumari, Pooja Mittal, Amit Kumar, Bharti Singal, Gulam M. Hasan, Rajiv Aggarwal, Md. Amjad Kamal, Archana Singh, Md. Imtaiyaz Hassan

Summary: COVID-19, caused by SARS-CoV-2, can be treated with plant-based materials and other drugs. Vaccines and DNA/RNA therapy have shown high clinical significance, while various forms of vitamins, minerals, herbs, and phytonutrients can enhance immunity against the virus. However, these measures should be combined with social distancing and quarantine.

CURRENT PHARMACEUTICAL DESIGN (2021)

Review Biotechnology & Applied Microbiology

Potential therapeutic targets of Klebsiella pneumoniae: a multi-omics review perspective

Sabeeha Ali, Manzar Alam, Gulam Mustafa Hasan, Md Imtaiyaz Hassan

Summary: The prolonged use of antibiotics has led to the development of multidrug resistance in many organisms, causing a global health crisis. Klebsiella pneumoniae is a causative organism for various infections and recently, both immunocompromised and healthy individuals are equally susceptible to K. pneumoniae infections due to the emergence of hypervirulent strains. This review discusses the pathophysiology of K. pneumoniae, including its virulence determinants, and explores potential drug targets for the discovery of novel drugs and effective treatment regimens.

BRIEFINGS IN FUNCTIONAL GENOMICS (2022)

Review Biochemistry & Molecular Biology

Therapeutic targeting of TANK-binding kinase signaling towards anticancer drug development: Challenges and opportunities

Manzar Alam, Md. Meraj Ansari, Saba Noor, Taj Mohammad, Gulam Mustafa Hasan, Syed Naqui Kazim, Md. Imtaiyaz Hassan

Summary: TBK1 plays a fundamental role in regulating cellular responses and controlling signaling cascades. Dysregulation of the TBK1 pathway is associated with various pathophysiological conditions. Inhibitors targeting TBK1 have potential therapeutic applications for diseases, including cancer.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Review Immunology

A comprehensive review on classifying fast-acting and slow-acting antimalarial agents based on time of action and target organelle of Plasmodium sp

Monika Mariebernard, Abhinab Mohanty, Vinoth Rajendran

Summary: This review focuses on the classification of antimalarial agents based on their killing time and the appearance of organelles during the intraerythrocytic development of Plasmodium falciparum. The study reveals that different drugs have different killing kinetics and target different organelles at different stages of parasite development. Understanding the timing and mechanism of antimalarial action is crucial for designing effective combination therapies and evaluating clinical resistance.

PATHOGENS AND DISEASE (2022)

Article Biochemistry & Molecular Biology

Therapeutic implications and clinical manifestations of thymoquinone

Manzar Alam, Gulam Mustafa Hasan, Md Meraj Ansari, Rishi Sharma, Dharmendra Kumar Yadav, Md Imtaiyaz Hassan

Summary: Thymoquinone (TQ), a natural phytochemical found in Nigella sativa, has been proven to have anti-cancer, anti-oxidant, and anti-inflammatory properties, and exhibits antitumor activity by modulating multiple pathways and molecular targets.

PHYTOCHEMISTRY (2022)

Article Pharmacology & Pharmacy

The Multistage Antimalarial Compound Calxinin Perturbates P. falciparum Ca2+ Homeostasis by Targeting a Unique Ion Channel

Yash Gupta, Neha Sharma, Snigdha Singh, Jesus G. Romero, Vinoth Rajendran, Reagan M. Mogire, Mohammad Kashif, Jordan Beach, Walter Jeske, Poonam, Bernhards R. Ogutu, Stefan M. Kanzok, Hoseah M. Akala, Jennifer Legac, Philip J. Rosenthal, David J. Rademacher, Ravi Durvasula, Agam P. Singh, Brijesh Rathi, Prakasha Kempaiah

Summary: A novel multistage antimalarial compound called Calxinin has been developed and exhibits potent inhibitory activity against drug-sensitive and drug-resistant strains of Plasmodium falciparum. It has a unique mechanism of action and shows potential therapeutic, prophylactic, and transmission-blocking properties against malaria parasites resistant to current antimalarials.

PHARMACEUTICS (2022)

Review Cell Biology

Microtubule-affinity regulating kinase 4: A potential drug target for cancer therapy

Saleha Anwar, Moyad Shahwan, Gulam Mustafa Hasan, Asimul Islam, Md. Imtaiyaz Hassan

Summary: The human genome encodes more than 500 protein kinases, many of which are associated with cancer. MARK4 is a protein kinase associated with various cancer types due to its important role in regulating microtubule dynamics and cell division. MARK4 is also linked to other pathologies such as Alzheimer's disease and obesity.

CELLULAR SIGNALLING (2022)

Review Biochemistry & Molecular Biology

Structure-guided design and development of cyclin-dependent kinase 4/6 inhibitors: A review on therapeutic implications

Mohd. Yousuf, Manzar Alam, Anas Shamsi, Parvez Khan, Gulam Mustafa Hasan, Qazi M. Rizwanul Haque, Md. Imtaiyaz Hassan

Summary: Cyclin-dependent kinase 6 (CDK6) plays a significant role in cancer and is considered an effective drug target for therapy. CDK4/6 inhibitors have shown promising anti-cancer activity by preventing tumor development through inhibiting Rb phosphorylation and E2F liberation. This article discusses the roles of CDK6 in cancer, the current status of CDK4/6 inhibitors in therapy, and emphasizes the potential of combining CDK4/6 inhibitors with other drugs for cancer treatment.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Article Biochemistry & Molecular Biology

Therapeutic targeting of Huntington's disease: Molecular and clinical approaches

Dhiraj Kumar, Gulam Mustafa Hasan, Asimul Islam, Md. Imtaiyaz Hassan

Summary: Huntington's disease is a common autosomal dominant disease that affects a large number of patients. Despite early genetic diagnostics, effective disease-modifying treatments are still lacking. Ongoing clinical trials are exploring potential drugs to alleviate symptoms by targeting the root cause at the molecular level. Although a major phase III trial was unexpectedly discontinued, there is still optimism about the potential of this technique.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2023)

Article Medicine, Research & Experimental

Investigating regulated signaling pathways in therapeutic targeting of non-small cell lung carcinoma

Manzar Alam, Gulam Mustafa Hasan, Sayed M. Eldin, Mohd Adnan, Muhammad Bilal Riaz, Asimul Islam, Ilyas Khan, Md. Imtaiyaz Hassan

Summary: Non-small cell lung carcinoma (NSCLC) is the most common malignancy worldwide. Genetic modifications in upstream signaling molecules stimulate signaling cascades, leading to cancer cell proliferation, cancer development, and drug resistance. Efforts have been made to understand the mechanisms of cancer development and develop effective therapeutic approaches for NSCLC by modifying transcription factors and targeting specific cellular signaling pathways in tumor progression. This comprehensive review provides deeper mechanistic insights into the molecular mechanism of action of various signaling molecules and their targeting in the clinical management of NSCLC.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Review Biochemistry & Molecular Biology

A review on regulation of cell cycle by extracellular matrix

Ashar Rais, Afzal Husain, Gulam Mustafa Hasan, Md. Imtaiyaz Hassan

Summary: The extracellular matrix (ECM) is a complex network that helps cells aggregate and form functional structures. It plays multiple roles in tissue structure and function, beyond its initial passive functions. The discovery of cellular receptors and their interaction with ECM components has opened new avenues for understanding the role of ECM in developmental programs, wound healing, and tumour progression. This review focuses on how ECM influences the progression of the somatic cell cycle and provides molecular insights into the communication between adhesion complex, signaling pathways, and cell cycle machinery.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2023)

Article Biochemistry & Molecular Biology

Investigating MARK4 inhibitory potential of Bacopaside II: Targeting Alzheimer's disease

Saleha Anwar, Taj Mohammad, Md. Khabeer Azhar, Hera Fatima, Afsar Alam, Gulam Mustafa Hasan, Asimul Islam, Punit Kaur, Md. Imtaiyaz Hassan

Summary: MARK4 is a kinase known for phosphorylating tau protein and causing Alzheimer's disease. Bacopa monnieri extracts have neuroprotective roles and have been used to treat neurological disorders. Bacopaside II shows strong binding affinity for MARK4 and inhibits its kinase activity.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2023)

Review Nutrition & Dietetics

Comprehensive Insights into Biological Roles of Rosmarinic Acid: Implications in Diabetes, Cancer and Neurodegenerative Diseases

Md. Khabeer Azhar, Saleha Anwar, Gulam Mustafa Hasan, Anas Shamsi, Asimul Islam, Suhel Parvez, Md. Imtaiyaz Hassan

Summary: Rosmarinic acid (RA) is an abundant phytochemical with anti-inflammatory and antioxidant properties, playing significant roles in cancer, neuroprotection, and diabetes.

NUTRIENTS (2023)

Review Chemistry, Multidisciplinary

Therapeutic Targeting of Regulated Signaling Pathways of Non-Small Cell Lung Carcinoma

Gulam Mustafa Hasan, Md. Imtaiyaz Hassan, Sukhwinder Singh Sohal, Anas Shamsi, Manzar Alam

Summary: Non-small cell lung carcinoma (NSCLC) is the most common cancer globally, and phytochemicals and small molecule inhibitors have been found to effectively prevent NSCLC and other types of cancers by regulating signaling pathways. This review focuses on the bioactive compounds and small-molecule inhibitors, such as EGCG, Perifosine, ABT-737, Thymoquinine, Quercetin, Venetoclax, Gefitinib, and Genistein, and discusses their potential in NSCLC therapy.

ACS OMEGA (2023)

No Data Available